Gene Therapy with P53 and a Fragment of Thrombospondin I Inhibits Human Breast Cancer in Vivo

Author： Xu M.   Kumar D.   Stass S.A.   Mixson A.J.  

Publisher： Academic Press

ISSN： 1096-7192

Source： Molecular Genetics and Metabolism, Vol.63, Iss.2, 1998-02, pp. : 103-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of p53 gene transfection on vascular endothelial growth factor expression in endometrial cancer cells

By Fujisawa T.   Watanabe J.   Kamata Y.   Hamano M.   Hata H.   Kuramoto H.  

Experimental and Molecular Pathology, Vol. 74, Iss. 3, 2003-06 ,pp. : 276-281

Elsevier

Access to resources Recommend Favorite

Characterization of Human Papillomavirus Infection, P53 and Ki-67 Expression in Cervix Cancer of Mozambican Women

By Carrilho Carla   Gouveia Patricia   Cantel Martha   Alberto Matos   Buane Landim   David Leonor  

Pathology Research and Practice, Vol. 199, Iss. 5, 2003-07 ,pp. : 303-311

Urban & Fischer

Access to resources Recommend Favorite

The prospects for cancer gene therapy

By De Giovanni C.   Nanni P.   Forni G.  

International Journal of Immunopharmacology, Vol. 22, Iss. 12, 2000-12 ,pp. : 1025-1032

Elsevier

Access to resources Recommend Favorite

The p53-Estrogen Receptor Loop in Cancer

By  

Current Molecular Medicine, Vol. 13, Iss. 8, 2013-09 ,pp. : 1229-1240

Bentham Science Publishers

Access to resources Recommend Favorite

The Promise and Obstacle of p53 as a Cancer Therapeutic Agent

By  

Current Molecular Medicine, Vol. 2, Iss. 4, 2002-06 ,pp. : 329-345

Bentham Science Publishers

Access to resources Recommend Favorite